1. Home
  2. YDDL vs FATE Comparison

YDDL vs FATE Comparison

Compare YDDL & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YDDL

One and One Green Technologies. Inc Class A Ordinary Shares

HOLD

Current Price

$1.21

Market Cap

104.8M

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$2.08

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YDDL
FATE
Founded
2014
2007
Country
Philippines
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.8M
125.6M
IPO Year
2024
2013

Fundamental Metrics

Financial Performance
Metric
YDDL
FATE
Price
$1.21
$2.08
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
★ $5.74
AVG Volume (30 Days)
20.5K
★ 1.3M
Earning Date
09-29-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 29.88
EPS
★ N/A
N/A
Revenue
N/A
★ $6,646,000.00
Revenue This Year
$25.83
N/A
Revenue Next Year
$23.91
N/A
P/E Ratio
$40.85
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.09
$0.95
52 Week High
$16.23
$3.23

Technical Indicators

Market Signals
Indicator
YDDL
FATE
Relative Strength Index (RSI) 35.72 44.29
Support Level $1.09 $1.81
Resistance Level $1.94 $2.60
Average True Range (ATR) 0.08 0.15
MACD 0.00 -0.01
Stochastic Oscillator 39.73 40.00

Price Performance

Historical Comparison
YDDL
FATE

About YDDL One and One Green Technologies. Inc Class A Ordinary Shares

One and one Green Technologies Inc is engaged in recycling, production, and trading of recycled scrap metals in the Republic of the Philippines. The company processes raw materials and generates final products that include copper alloy ingots, aluminum scrapes, plastic beads, and others. It provides economical and flexible solutions to the challenges of electronic waste, metal scrap, and industrial recycling. The company operates and manages its business as a single segment and has one operating and reportable segment, trading of recycled scrap metals. Geographically, it generates the majority of its revenue from China.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: